Literature DB >> 12134771

The global emergency of tuberculosis: what is the cause?

J M Grange1, A Zumla.   

Abstract

The treatment of tuberculosis is cheap and highly effective, yet worldwide the disease remains a serious cause of illness and death; so serious as to have been declared a 'global emergency' in 1993. It is principally a disease of poverty, with 95% of cases and 98% of deaths occurring in developing countries. The incidence of tuberculosis is increasing worldwide, partly due to poverty and inequity and partly to the HIV/AIDS pandemic, which greatly increases the risk of infection proceeding to overt disease. Around 30% of AIDS-related deaths are due to tuberculosis. The emergence of multidrug resistant tuberculosis (MDRTB) is an increasing threat to tuberculosis control. Although treatable with alternative drugs, the cost is enormous and, accordingly, not undertaken in many poor nations. While the overall global incidence of MDRTB is low, it occurs in certain 'hotspots' including Russian prisons. Due to adverse socio-economic factors, London has not escaped the general rise in incidence and, without the introduction of active control strategies, there could be a serious epidemic as occurred in New York City ten years ago which required an enormous financial outlay for its control. In view of the global emergency of tuberculosis, the WHO 'Stop TB' campaign has called for the universal adoption of its directly observed therapy, short course (DOTS) strategy. Also, though the Massive Effort Against Diseases of Poverty, several international agencies are urging the establishment of effective control programmes worldwide. London should take the lead and set an example.

Entities:  

Mesh:

Year:  2002        PMID: 12134771     DOI: 10.1177/146642400212200206

Source DB:  PubMed          Journal:  J R Soc Promot Health        ISSN: 1466-4240


  21 in total

Review 1.  Addressing the "risk environment" for injection drug users: the mysterious case of the missing cop.

Authors:  Scott Burris; Kim M Blankenship; Martin Donoghoe; Susan Sherman; Jon S Vernick; Patricia Case; Zita Lazzarini; Stephen Koester
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

2.  Kinetic and chemical mechanism of arylamine N-acetyltransferase from Mycobacterium tuberculosis.

Authors:  Alison L Sikora; Brenda A Frankel; John S Blanchard
Journal:  Biochemistry       Date:  2008-09-17       Impact factor: 3.162

3.  Diagnosis of tuberculosis: urgent need to strengthen laboratory services.

Authors:  Aderemi O Kehinde; Festus A Obaseki; Solomon I Cadmus; Raheed A Bakare
Journal:  J Natl Med Assoc       Date:  2005-03       Impact factor: 1.798

4.  Tuberculosis - persistent threat to human health.

Authors:  Y K Amdekar
Journal:  Indian J Pediatr       Date:  2005-04       Impact factor: 1.967

Review 5.  Paleomicrobiology: a Snapshot of Ancient Microbes and Approaches to Forensic Microbiology.

Authors:  Jessica I Rivera-Perez; Tasha M Santiago-Rodriguez; Gary A Toranzos
Journal:  Microbiol Spectr       Date:  2016-08

6.  Drug-susceptibility patterns of Mycobacterium tuberculosis in Mpumalanga province, South Africa: possible guiding design of retreatment regimen.

Authors:  E Green; C L Obi; M Nchabeleng; B E de Villiers; P P Sein; T Letsoalo; A A Hoosen; P O Bessong; R N Ndip
Journal:  J Health Popul Nutr       Date:  2010-02       Impact factor: 2.000

7.  Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016.

Authors:  Arundhati Maitra; Tengku Karmila Kamil; Monisha Shaik; Cynthia Amaning Danquah; Alina Chrzastek; Sanjib Bhakta
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

Review 8.  The impact of COVID-19 on tuberculosis: challenges and opportunities.

Authors:  Surya Kant; Richa Tyagi
Journal:  Ther Adv Infect Dis       Date:  2021-06-09

9.  Improving the Potency of N-Aryl-2,5-dimethylpyrroles against Multidrug-Resistant and Intracellular Mycobacteria.

Authors:  Meir Touitou; Fabrizio Manetti; Camila Maringolo Ribeiro; Fernando Rogerio Pavan; Nicolò Scalacci; Katarina Zrebna; Neelu Begum; Dorothy Semenya; Antima Gupta; Sanjib Bhakta; Timothy D McHugh; Hanoch Senderowitz; Melina Kyriazi; Daniele Castagnolo
Journal:  ACS Med Chem Lett       Date:  2019-12-10       Impact factor: 4.345

10.  Effectiveness of involving the private medical sector in the National TB Control Programme in Bangladesh: evidence from mixed methods.

Authors:  Abu Naser Zafar Ullah; Rumana Huque; Ashaque Husain; Salma Akter; Akramul Islam; James Nicholas Newell
Journal:  BMJ Open       Date:  2012-12-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.